SWTX — SpringWorks Therapeutics Share News
0.000.00%
Last trade - 00:00- $3.54bn
- $3.25bn
- $191.59m
Brief: Springworks Therapeutics Expects Nirogacestat Decision From European Commission In Q3
Brief: EMA's CHMP Re-Examines Rejection Of Kisunla For Early Alzheimer’S Treatment
Brief: SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN
Brief: SpringWorks Therapeutics Receives Positive CHMP Opinion For Mirdametinib For The Treatment Of Adult And Pediatric Patients With NF1-PN
SpringWorks Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Deals of the day - Mergers and acquisitions
U.S. RESEARCH ROUNDUP-Domino's Pizza, Prologis, Springworks Therapeutics
U.S. STOCKS ON THE MOVE-Nvidia, Sabre, Biohaven
U.S. STOCKS ON THE MOVE-Marriott, Wells Fargo, Insulet
U.S. STOCKS ON THE MOVE-Domino's Pizza, Eli Lilly, Revvity
U.S. STOCKS ON THE MOVE-Domino's Pizza, Eli Lilly, gold miners
SpringWorks Therapeutics rises after Germany's Merck KGaA to buy co in $3.9 bln deal
Merck KGaA says the agreed bid for SpringWorks is final
Brief: SpringWorks Therapeutics Says Co To Pay Merck KGaA $145.6 Million Termination Fee If Deal Is Terminated Under Some Circumstances
Press Digest: Wall Street Journal - April 28
Germany's Merck KGaA in $3.9 billion deal to buy US biotech firm SpringWorks (updated)
Brief: Merck Says Transaction Approved, Expected To Close In Second Half 2025
Germany's Merck KGaA in $3.9 bln deal to acquire US biotech firm SpringWorks
Press Digest: Wall Street Journal - April 25